But I want to express how absolutely inspired I have been by the many brilliant women I've had the opportunity to work with this year & throughout my career!π
I absolutely remember how important it was (and is!) to be able to see myself in women who were in positions I aimed to achieve. Representation matters *so much.*
It helps to break down the expectations & stereotypes we often unknowingly internalise & realise what's possible!
Just 1 anecdote:
The first time I heard a brilliant women scientist whom I admired matter-of-factly state that she was looking forward both to the conference ποΈ /and/ to shoe-shopping π in the city it was in was *a revelation* for me. π€―
I'd internalized that being a scientist & programmer meant not enjoying stereotypically "girly" things, like shoes, makeup, and nice dresses. π«π
Or if I did, I needed to hide them in a work setting, or I might be dismissed as 'not serious' or 'air-headed'. π
Seeing a successful, respected women scientist be open about something she enjoyed (even if "girly" & "stereotypical") gave me permission to /be myself/.
This is just my story: I know other women have felt the opposite - that being a women in a professional environment meant they *had* to like makeup & heels.
Let's take a quick look at some snapshots of what we can see in the latest data.
1/15
Important note: the S:N501 build is now being more significantly impacted by downsampling.
I'm working on addressing this, but in the meantime, suggest looking at the S:E484 build for 501Y.V2 & 501Y.V3 & checking out the CoV Lineages report! cov-lineages.org/global_report.β¦
2/15
Israel now has over 200 sequences in 501Y.V1 (B.1.1.7). The latest additions indicate separate introductions (mostly from a month or two ago) and a large and still-growing local cluster.
As well as the major variants of concern, we can spot a couple of other clusters stemming from an 'old' #SARSCoV2 clade, 19B (originating in late 2019).
19A & 19B haven't been around much since early 2020, as they were overtaken by 20A, B & C (which carry D614G).
2/5
However, a few branches of 19B seem to be popping back up again recently.
In the UK, we can see a recent cluster that's acquired S:E484K (along with other mutations in S).
I'm still getting a *lot* of media enquiries - more than I can even respond to! So here's some of my best tips for how to reach out to me to maximise your chances of success (though I imagine they're true of other scientists too!)
1/7
(Just as a disclaimer - even if you use all of these, I can't promise I write back, or that I can say yes. If emails slip off the 'front page' of my inbox they basically fall into a black hole π¬. And sometimes I just cannot take any more interviews, even great ones.)
2/7
1. Please tell me what time zone you're in!
If I want to say 'yes' that means a pencilled-in appointment goes into the calendar immediately - so I need to know when you're likely to be awake. If I have to email you to find out... it might not happen.
3/7
We're hoping to make this a one-stop location to track not only the 'headline' variants, but many different #SARSCoV2 mutations & variants that scientists are keeping an eye on.
Let's take a tour of the site!
1/12
The buttons on the left will take you to pages focused on key variants & mutations, while the menu at the top will help you jump between info pages (FAQ) & pages compiling together information about many variants (ex: Per country).
Let's take a look at the 20A.EU1 page
2/12
Here, we can
- Click through to a dedicated @Nextstrain build for the variant (1)
- See a list of the defining mutations (2)
- Learn a bit about the variant & see links to papers (3)
- See a distribution of 20A.EU1 per country (4)
- See a protein model! (pic 2)
In the 501Y.V1 (B.1.1.7) variant, here are a few of the non-UK countries with new sequences in this variant, including Denmark, Italy, Spain, France, Portugal, Norway, Germany, the USA, South Kora, & Switzerland, & the UAE, Austria, & Czech Republic for the 1st time
2/18
Denmark has 52 new samples (some yellow), showing both separate introductions and further spread of existing local clusters.